The effects of postmenopausal hormone therapy on social activity, partner relationship, and sexual life - Experience from the EPHT trial

被引:3
作者
Hemminki E. [1 ]
Veerus P. [2 ]
Pisarev H. [3 ]
Hovi S.-L. [4 ]
Topo P. [1 ]
Karro H. [5 ]
机构
[1] Health Services and Policy Research, National Institute for Health and Welfare (THL), 00271 Helsinki
[2] Department of Epidemiology and Biostatistics, National Institute for Health Development (TAI), 11619 Tallinn
[3] Department of Public Health, Tartu University, 50411 Tartu
[4] Finnish Office for Health Technology Assessment (Finohta), National Institute for Health and Welfare (THL), 00271 Helsinki
[5] Department of Obstetrics and Gynecology, University of Tartu, 51003 Tartu
基金
芬兰科学院;
关键词
Hormone Therapy; Sexual Functioning; Sexual Life; Final Survey; Social Involvement;
D O I
10.1186/1472-6874-9-16
中图分类号
学科分类号
摘要
Background: With the exception of sexual functioning and weight, social and behavioural effects of postmenopausal hormone therapy (HT) have not been reported from trials. This paper reports such results from the EPHT-trial in Estonia. Methods: A randomized trial, with a blind and non-blind sub-trial in Estonia. From 1999-2001, 1778 women were recruited. The mean follow-up was 3.6 years. Women's experiences were asked in the first and final study year by mailed questionnaires (74 and 81% response rates). Comparisons of the groups were made by cross-tabulation and logistic regression, adjusting for age. Results: There were no differences between the HT and non-HT groups in regard to being employed, the extent of social involvement or marital status or opinions on aging. There was no difference in the frequency of free-time exercise, or overweight. Some of the indicators suggested less sexual inactivity, but the differences were small. Conclusion: In a trial setting, postmenopausal hormone therapy did not influence work or social involvement or health behaviour. copy; 2009 Hemminki et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 32 条
  • [1] Topo P., Climacteric hormone therapy in medical and lay texts in Finland from 1955 to 1992, Soc Sci Med, 45, pp. 751-760, (1997)
  • [2] Siegel Watkins E., The Estrogen Elixir. A History of Hormone Replacement Therapy in America, (2007)
  • [3] Nilsen S.T., Pedersen A.T., Moen M.H., Milsom I., Mattsson L.A., Iversen O.E., Larsen P.M., Andersson K., Knowledge, attitudes and management strategies in Scandinavia concerning hormone replacement therapy. A comparison between gynecologists in Denmark, Norway and Sweden, Maturitas, 39, pp. 83-90, (2001)
  • [4] Baron J., Holzman G.B., Schulkin J., Attitudes of Obstetricians and Gynecologists toward Hormone Replacement Therapy, Psychol Decis Making, 18, pp. 406-411, (1998)
  • [5] Hemminki E., Topo P., Prescribing hormone therapy in menopause and postmenopause, J Psychosom Obstet Gynecol, 18, pp. 145-157, (1997)
  • [6] Hovi S.-L., Karttunen T., Karro H., Hemminki E., Comparison of Estonian and Finnish physicians' opinions of menopause and hormone therapy, Maturitas, 49, pp. 107-113, (2004)
  • [7] Hemminki E., Topo P., Malin M., Kangas I., Physicians' views on hormone therapy around and after menopause, Maturitas, 16, pp. 163-173, (1993)
  • [8] Hunt K., Perceived value of treatment among a group of long-term users of hormone replacement therapy, J R Coll Gen Pract, 38, pp. 398-401, (1988)
  • [9] Kadri A.Z., Hormone replacement therapy - A survey of perimenopausal women in a community setting, Br J Gen Pract, 41, pp. 109-112, (1991)
  • [10] Limouzin-Lamothe M.-A., What women want from hormone replacement therapy: Results of an international survey, Eur J Obstet Gynecol Reprod Biol, 64, SUPPL. 1, (1996)